Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population
暂无分享,去创建一个
[1] S. Akhtar,et al. Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy , 2022, Medicina.
[2] M. Nasr-Esfahani,et al. The NLRP3 inflammasome: molecular activation and regulation in spermatogenesis and male infertility; a systematic review , 2022, Basic and Clinical Andrology.
[3] Yonas Akalu,et al. Association of IL-10 (− 1082 A/G) and IL-6 (− 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population , 2021, BMC Endocrine Disorders.
[4] J. Navarro-González,et al. Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications , 2021, Frontiers in Medicine.
[5] B. Satirapoj,et al. Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand , 2020, Journal of diabetes research.
[6] Chao Liu,et al. Research Progress on the Role of Inflammasomes in Kidney Disease , 2020, Mediators of inflammation.
[7] Jieqiong Lou,et al. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis. , 2019, The International journal of health planning and management.
[8] M. Shirakawa,et al. An innate interaction between IL-18 and the propeptide that inactivates its precursor form , 2019, Scientific Reports.
[9] N. Hadi,et al. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy. , 2019, Diabetes & metabolic syndrome.
[10] S. Atkin,et al. Interleukin‐18 and diabetic nephropathy: A review , 2018, Journal of cellular physiology.
[11] S. Dinneen,et al. What is diabetes? , 2006, Medicine.
[12] N. Moradi,et al. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6. , 2019, Cytokine.
[13] Vahideh Hassan-Zadeh,et al. Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes , 2018, Immunological investigations.
[14] A. Sahebkar,et al. Oxidative stress induces renal failure: A review of possible molecular pathways , 2018, Journal of cellular biochemistry.
[15] Z. Bashir,et al. Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study , 2017, World journal of diabetes.
[16] Chun Zhang,et al. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update , 2017, Front. Immunol..
[17] Y. Qing,et al. Associations Between Hyperuricemia and Chronic Kidney Disease: A Review , 2015, Nephro-urology monthly.
[18] J. Navarro-González,et al. Inflammatory Cytokines in Diabetic Nephropathy , 2015, Journal of diabetes research.
[19] N. Agrawal,et al. Targeting inflammation in diabetes: Newer therapeutic options. , 2014, World journal of diabetes.
[20] A. Rubio-Guerra,et al. Diabetic nephropathy and inflammation. , 2014, World journal of diabetes.
[21] Y. Zha,et al. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis , 2014, Journal of Nephrology.
[22] K. Al-Rubeaan,et al. Diabetic Nephropathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study , 2014, PloS one.
[23] D. Maixnerova,et al. The coincidence of IgA nephropathy and Fabry disease , 2013, BMC Nephrology.
[24] G. Tesch,et al. Inflammation in Diabetic Nephropathy , 2012, Mediators of inflammation.
[25] S. Barra,et al. Glomerular filtration rate, Which formula should be used in patients with myocardial infarction? , 2012 .
[26] D. Maahs,et al. Uric acid as a mediator of diabetic nephropathy. , 2011, Seminars in nephrology.
[27] Koichi Matsumoto,et al. Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. , 2011, Diabetes Research and Clinical Practice.
[28] M. Ares,et al. Purification of RNA using TRIzol (TRI reagent). , 2010, Cold Spring Harbor protocols.
[29] R. Khalil,et al. Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.
[30] M. Netea,et al. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus , 2008, International Journal of Obesity.
[31] R. Bank,et al. Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect. , 2007, Biochemical and biophysical research communications.